Pfizer reported that its two-dose COVID-19 vaccine is 100% effective at preventing infection of the highly contagious variant first detected in South Africa.

The company also reported that the two-dose vaccine developed with German firm BioNTech provided continued high levels of protection against illness for six months after the shots were administered, setting the manufacturer on the path toward full regulatory approval from the federal government.